In Vitro Skin Models and Their Predictability in Defining Normal and Disease Biology, Pharmacology, and Toxicity

Utility of Scalp Hair Follicles as a Novel Source of Biomarker Genes for Psychiatric Illnesses

(2015) Motoko Maekawa et al.   BIOLOGICAL PSYCHIATRY

Cutaneous adverse effects of targeted therapies

(2015) James B. Macdonald et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma

(2014) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cutaneous toxicities of BRAF inhibitors: Clinical and pathological challenges and call to action

(2013) Mario Mandalà et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The Yin and Yang of Immunomodulatory Biologics: Assessing the Delicate Balance between Benefit and Risk

(2012) Dimitry M. Danilenko et al.   TOXICOLOGIC PATHOLOGY

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

(2010) P. M. LoRusso et al.   CLINICAL CANCER RESEARCH

In vitro models for human skin disease

(2010) Lydia Semlin et al.   DRUG DISCOVERY TODAY

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

(2010) Georgia Hatzivassiliou et al.   NATURE